Akebia Therapeutics
In Seth Klarman's portfolio · Baupost Group
Ticker AKBA
Not in the portfolio as of Q3 2026. Every quarter it shows up in a Baupost Group 13F, newest first.
| Quarter | Activity | Shares | Weight |
|---|---|---|---|
| Q3 2020 | Sell | 0 | |
| Q2 2020 | Reduce 14% | 15,000,000 | 2.5% |
| Q1 2020 | Reduce 10% | 17,527,968 | 2.0% |
| Q4 2019 | Reduce 20% | 19,571,453 | 1.4% |
| Q3 2019 | No change | 24,471,453 | 1.1% |
| Q2 2019 | No change | 24,471,453 | 1.1% |
| Q1 2019 | No change | 24,471,453 | 1.7% |
| Q4 2018 | Buy | 24,471,453 | 1.2% |
Price is the position's value divided by its shares, at the end of each quarter. Share counts are as filed; when a stock split happened, the change is measured on split-adjusted shares.